Sunshine Biopharma Inc.
(NASDAQ:SBFM) shares are trading lower in after-hours trading on Thursday.
SBFM shares fell 5.17% to $0.30 in after-hours trading after the company announced a one-for-ten reverse stock split, effective at market open on June 1, 2026.
Sunshine Biopharma is a pharmaceutical company focused on generic prescription drugs, over-the-counter supplements and the development of proprietary treatments in oncology and antiviral therapeutics.
Reverse Stock Split The company said the reverse stock split was undertaken to regain compliance with Nasdaq's minimum bid price requirement for continued listing.
